Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
about
Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactionsImmunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast CancerReconnoitring the status of prostate specific antigen and its role in womenNuclear actions of insulin-like growth factor binding protein-3Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cellsRole of insulin-like growth factor binding protein-3 in breast cancer cell growthTumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated antiapoptotic activity of nerve growth factor in breast cancer cellsPlasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern SwedenDoes growth hormone cause cancer?Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cellsLocal IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas.Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis.Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinomaThe diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage.Signalling pathways involved in antiproliferative effects of IGFBP-3: a review.Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells.Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.IGFBP3 mRNA expression in benign and malignant breast tumorsWhat's new in the IGF-binding proteins?Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer.Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk.Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines.Prolactin acts as a potent survival factor for human breast cancer cell lines.Synthetic retinoid fenretinide in breast cancer chemoprevention.Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma.Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.Advances in novel drug delivery strategies for breast cancer therapy.Role of insulin-like growth factor binding protein-3 in glucose and lipid metabolism.Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.Identification of STAT-1 as a molecular target of IGFBP-3 in the process of chondrogenesis.Characterization of a novel positive transcription regulatory element that differentially regulates the insulin-like growth factor binding protein-3 (IGFBP-3) gene in senescent cells.Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3
P2860
Q24533385-625C2879-D99A-40BF-8384-E9EC749B2460Q24796824-817E1A3A-96AE-4E8B-B0A8-E128CEC8F0E7Q26801886-94119222-A264-4D5B-AD51-F07BDD5FDB74Q26995569-3E35F1EC-F50B-49E5-85BF-8399F3778087Q28080513-D4330E3F-2F38-4884-B5E5-F79FCF213A7CQ28087055-53EA2818-8CD3-4CC9-AEE8-44207C734907Q28139221-94CE9C0C-8D77-42BC-AD9C-09D12B8D1127Q28202893-EE8769BF-FDE1-49F3-864A-246FFD3159B4Q28211942-E4E4CE3D-E749-4F86-937A-2F6ED3E7309DQ28214565-A4E4F2F2-9A6B-46C3-A091-61925421FA86Q28293263-2B6A9180-28A5-4C63-B087-2E66BD579398Q28564423-668FB071-6B63-4EC5-9335-9FD7F33E0C10Q33337232-2FE3FEEB-09F9-41D6-A9EE-461A3F52B39AQ33625732-DF43FBD0-60D0-4F7E-92FC-C14804DA87BFQ33685277-7C06944F-D7F9-4605-B50F-68EA9404308FQ33884420-B86DEF79-48E4-42C5-89B2-C70BD93FCC85Q33958230-34826232-8F52-44FA-9690-D209379B59AFQ34079892-EB346F13-C7FE-4FA1-B44B-6F808A4DC060Q34263336-A6673D72-EF99-4ED7-855F-6266C5126DCAQ34695649-80E20B9F-D46C-40F8-A5C9-493BD4223801Q34805398-D1A97108-8FDD-4B63-B5D6-3CA08E60125BQ35001398-680DF328-BEED-4D7E-ACB4-94169AB580C1Q35749398-17B32AAA-7F48-4AFA-AFB9-0E975932219EQ35874076-8CA01922-FD23-482A-9F54-580503D5B94BQ36094078-E2081691-4FA4-43C6-AB30-6869DA96F4FAQ36413546-82F56728-7C2D-4776-9789-51A7F704E359Q36616549-F7FBD7E3-E31A-409E-8835-BDD1EF33E18FQ36618848-4A0087C3-D3E2-4B5F-BBBA-30C3F919EAD7Q36695290-D03F2DEA-8696-4557-A3DC-FBB649EC59DEQ36788454-CFCC32F4-4ED8-40C9-87E2-7CBFE6D181A3Q36817315-7EE10EBF-10A2-4A41-A06E-EE605B0284D7Q37004744-A8953D5E-B4B3-4357-AB61-5F08E833BCE2Q37777142-8D8B55E1-76A3-4E1A-A6AC-660AE00A455EQ38218132-522AC442-C94D-4D25-84BB-B74B3624A5E0Q38283730-8CB67B20-6DC8-48DB-9095-72C1D955CA62Q38291320-953EC4D4-1C90-449A-8350-B9E825BA986FQ38328298-B495AC80-7145-4206-A596-90FD923B800BQ38687230-D3BD3DA1-5CFB-4CED-A0B8-5F3F8D5CA7C0Q39449572-8714B6C4-CCAB-4946-89F7-F0A0A38E09CCQ39455066-2F45A9FD-BFB3-412F-B258-516D9FF51651
P2860
Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
description
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1997
@ast
im Oktober 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 10 October 1997)
@en
vedecký článok (publikovaný 1997/10/10)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/10/10)
@nl
наукова стаття, опублікована в жовтні 1997
@uk
name
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@ast
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@en
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@nl
type
label
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@ast
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@en
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@nl
prefLabel
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@ast
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@en
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@nl
P2093
P2860
P3181
P356
P1476
Insulin-like growth factor-bin ...... in a non-IGF-dependent manner
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.272.41.25602
P407
P577
1997-10-10T00:00:00Z